Sep 2026 consolidated quarter vs Sep 2025: revenue ₹4,914.65m vs ₹4,502.65m; loss ₹297m vs ₹149.5m

Net loss reportedEBITDA margin compressionExceptional itemResults View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-18.0%Reaction day

₹91.51

prior close

₹84.30

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.2%-20.2% vs market

Specialty Chemicals peers, median of 98sector+1.3%-19.3% vs sector

On the reaction day the stock moved 20.2 pts less than Nifty Microcap 250 and 19.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-3.7

15m

-3.5

30m

-4.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-18.0+2.2-20.2+1.3-19.3

Next day

-17.0+3.3-20.3+2.2-19.2

-16.7pendingpending+1.0-17.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 98Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated quarter ended September 30, 2026: revenue was Rs 4,914.65 million versus Rs 4,502.65 million a year earlier, while loss after tax widened to Rs 297.00 million from Rs 149.50 million. EBITDA margin fell to 0.45 percent from 7.91 percent; Rs 19.26 million of open-offer costs were exceptional. The Board approved a rights issue of up to Rs 250 crore and noted SEBI's warning over disclosure violations; terms and approvals are pending.

Likely market impact

Higher loss and weak margin may pressure the stock; shareholders not joining the rights issue face dilution, while SEBI's warning adds concern.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹491.5 Cr	₹459.8 Cr	+6.9%
Operating profit	−₹38.28 Cr	−₹4.32 Cr	loss widened
Profit after tax	−₹29.70 Cr	−₹14.95 Cr	loss widened
EBITDA margin	0.1%	7.3%	−7.2 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.